Startups around the world are engaging in clinical trials in a sector that could change lives – and be worth more than £15bn by the 2030s
Oran Knowlson, a British teenager with a severe type of epilepsy called Lennox-Gastaut syndrome, became the first person in the world to trial a new brain implant last October, with phenomenal results – his daytime seizures were reduced by 80%.
“It’s had a huge impact on his life and has prevented him from having the falls and injuring himself that he was having before,” says Martin Tisdall, a consultant paediatric neurosurgeon at Great Ormond Street Hospital (Gosh) in London, who implanted the device. “His mother was talking about how he’s had such a improvement in his quality of life, but also in his cognition: he’s more alert and more engaged.”
About Author
More Stories
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Microsoft unveils chip it says could bring quantum computing within years
Patients with long Covid regain sense of smell and taste with pioneering surgery